Abstract:Most patients in need of renal replacement therapy use peritoneal or hemodialysis (HD) therapy. Major drawbacks of HD are the incomplete removal of uremic solutes (especially middle-sized uremic solutes and protein-bound uremic solutes, PBUTs) as well as the non-continuous therapy (3 times per week for 4 h), causing large fluctuations in water balance and uremic waste, potassium, and phosphate. For achieving better patient outcomes, more continuous therapies are required including the application of home HD or portable HD. The latter require membranes with excellent long-term biocompatibility. Heparin-modified dialysis membranes can offer improved biocompatibility, but systemic anticoagulation is still needed, whereas potential heparin-induced thrombocytopenia (HIT) may occur. Glycosaminoglycans (GAGs) contribute to the kidney glomerular filtration barrier and provide natural anti-fouling properties. Here, we hypothesized that the incorporation of GAGs within polymeric membranes, either via membrane coating, post membrane fabrication, or via blending GAGs into the membrane forming polymer matrix, would provide membranes with improved hemocompatibility. We implemented these strategies to mixed matrix membranes (MMMs) which combine diffusion and adsorption for removing a broad range of uremic solutes. Firstly, we fabricated flat sheet MMMs with various GAG sources, including heparan sulphate from bovine kidney (HSBK), heparinase III-digested HSBK, HS isolated from cultured glomerular endothelial glycocalyx, GAGs from porcine intestinal mucosa (danaparoid, DA), or heparin. The flat sheet MMMs with DA blended within the membrane selective layer have excellent blood compatibility, based on a panel of anti-coagulation and immune activation assays, combined to high water transport and very low albumin leakage. Besides, these MMMs had low clot formation, did not activate immune cells or the complement system and had low platelet adhesion. Based on these findings, we also developed first hollow fiber MMMs with DA blended in the selective layer, which also had high water transport, no leakage of protein, and achieved very good removal of various uremic solutes, comparable to commercial HD membranes.

Inhibiting advanced glycation end products (AGEs) of high-performance hemodialysis membranes self-assembled by gallic acid and Ti3C2Tx MXene

Nb2CTx MXene coating with inhibition of oxidative stress prepared by Marangoni effect for hemodialysis therapy

Antioxidative hydrogel-embedded polyethersulfone membrane with improved hemocompatibility to alleviate oxidative stress

Tannic acid and Poly(N-acryloyl morpholine) layer-by-layer built hemodialysis membrane surface for intervening oxidative stress integrated with high biocompatibility and dialysis performance

Preparation and performance study of heparinized multi‐walled carbon nanotube/cellulose acetate hemodialysis membrane

Ceramic nanofiber membrane anchoring nanosized Mn<sub>2</sub>O<sub>3</sub> catalytic ozonation of sulfamethoxazole in water

Anticoagulant and antioxidant properties of hemodialysis membranes modified by hydrogels incorporating carbon dots

Engineering of hemocompatible and antifouling polyethersulfone membranes by blending with heparin-mimicking microgels

MXene Sorbents for Removal of Urea from Dialysate: A Step Toward the Wearable Artificial Kidney

Hierarchical Surface Architecture of Hemodialysis Membranes for Eliminating Homocysteine Based on the Multifunctional Role of Pyridoxal 5'-phosphate

A high-protein retained PES hemodialysis membrane with tannic acid as a multifunctional modifier

Optimal cross-linking of MXene-based membranes for high rejection and low adsorption with long-term stability for water treatment

Mixed matrix membranes with incorporated glycosaminoglycans have good blood biocompatibility combined to high toxin removal

Azido-group Functionalized Graphene Oxide/polysulfone Mixed Matrix Ultrafiltration Membrane with Enhanced Interfacial Compatibility for Efficient Water and Wastewater Treatment

Endothelial membrane mimetic coating modified dialyzer for hemocompatible and anticoagulant-free hemodialysis

Tree‐like PA6/PVP/CS hemodialysis membrane to improve the contradiction between medium molecular toxins and proteins

MXene: An efficient hemoperfusion sorbent for the removal of uremic toxins

Construction of electro-neutral surface on dialysis membrane for improved toxin clearance and anti-coagulation/inflammation through saltwater fish inspired trimethylamine N-oxide (TMAO)

Elution-free hollow-fiber membranes of block copolymers for hemodialysis balancing protein retaining and toxin clearance

MXene confined microcapsules for uremic toxins elimination

Hybrid functional membranes through layer-by-layer assembly of Ti3C2Tx MXene and gelatin-stabilized calcium phosphate nanospheres